Correction: Consensus estimates on Tryg A/S

*Correction of consensus estimates, specifically pertaining to the net profit for 2026 and 2027.

Tryg has compiled consensus estimates ahead of the interim report Q2 and H1 2025. Consensus is based on input from 12 financial analysts.

Consensus is also available on tryg.com.

Attachment

• Q2 2025 - Consensus

You May Also Be Interested In

• Kyungdong Pharmaceutical and Asimov Announce Completion of Cell Line Development Campaign for Biosimilar Antibody
• Element Submits Proposal to Acquire FleetPartners Group
• Second PIC/S GMP Certification | Mabwell Passes Brazilian GMP Inspection for Its Denosumab Injections